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INTRODUCTION 
Carbon tetrachloride (CCl4) is a well-established hepatotoxin, and metabolism of CCl4 via 
the cytochrome P450 system produces free radicals, including trichoromethyl radical and 
trichoromethyl peroxy radical [1,2]. Overproduction of these radicals initiates lipid 
peroxidation of polyunsaturated fatty acid in membrane and eventually leads to cell necrosis. 
These free radicals also react with antioxidants such as glutathione [3] and cause the depletion 
of glutathione in liver [4]. Additionally, CCl4 causes free toxic radical generation in kidneys 
[5,6]. Various studies demonstrate that some antioxidants protect the liver and kidney from the 
oxidative damage induced by CCl4 [6-8]. 
Low-dose irradiation induces various stimulating effects on living organs, especially the 
activation of biological defense system such as antioxidative [9-13] and immune functions 
[14,15]. For example, low-dose irradiation increases endogenous antioxidants in animal tissue. 
It has been reported that antioxidants such as superoxide dismutase (SOD) [11,16], 
glutathione peroxidase (GPx) [16], glutathione reductase (GR) [10], glutathione [10,16], 
catalase [16], and thioredoxin [16] are activated and/or induced by low-dose irradiation. 
Low-dose X- or γ-irradiation activate antioxidative functions in some organs and inhibit 
oxidative injury [17-22]. We have reported that pretreatment with low-dose X-irradiation 
inhibited CCl4-induced hepatopathy in mice with a catalase deficiency (acatalasemic mice). 
However, there were no significant differences in CCl4-induced hepatopathy between normal 
mice pretreated with low-dose radiation and acatalasemic mice pretreated with low-dose 
radiation because GPx activity in the liver of acatalasemic mice is significantly higher than 
that of normal mice. These findings indicate that the free radical accumulation induced by the 
lack of catalase and the administration of CCl4 is more completely neutralized by high GPx 
activity and low-dose irradiation in acatalasemic mice [17]. We also reported that the effects 
of post-treatment with low-dose (0.5 Gy) X-irradiation reduced the oxidative damage 
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associated with CCl4-induced hepatopathy in acatalasemic mice. These findings suggest that 
low-dose irradiation after CCl4 administration accelerates the rate of recovery and that 
catalase plays an important role in the recovery from hepatopathy induced by CCl4 [18]. 
Moreover, we reported that low-dose X-irradiation inhibited ischemia-reperfusion injury in 
mouse paw [20] and that low-dose irradiation of the extirpated mouse liver (not whole body) 
increased the activity of SOD and catalase [9]. It is highly possible that low-dose 
X-irradiation activates the defensive systems in the living body and, therefore, contributes to 
preventing or reducing reactive oxygen species (ROS)-related injuries, which are thought to 
involve peroxidation. 
Therapy involving radon gas volatilized from radon-enriched water is performed for various 
diseases at Misasa Medical Center, Okayama University Hospital. Most conditions treated 
with radon therapy are lifestyle-related diseases such as arteriosclerosis, osteoarthritis [23], 
and bronchial asthma [24]. To assess the effects of radon, we have co-developed a radon 
exposure system (OZ PLAN Co., Ltd. Okayama, Japan); radon inhalation using this system 
activated antioxidative functions in the liver, kidney, lung, and brain of mice, including 
suggesting the possibility of a new therapy to treat liver, kidney, lung, and brain damage [25]. 
Although hepatic and renal damage are not the main indication for radon therapy, radon 
inhalation therapy may mitigate liver and kidney damage. However, there have been no 
reports of the protective effect of radon inhalation on liver and kidney damage. 
The purpose of this study was to assess the effects of radon inhalation on CCl4-induced 
hepatic and renal damage. We examined the following biochemical and histological 
parameters to assess the effects of radon treatment on antioxidative functions: total 
glutathione content (t-GSH), GPx and GR activity, and lipid peroxide levels in livers and 
kidneys; glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT) and 
alkaline phosphatase (ALP) activity, and creatinine (CRE) and total cholesterol (T-CHO) in 
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serum; triglyceride level (TG) in liver; and histological examination of liver and kidney 
tissue. 
 
MATERIALS AND METHODS 
Conditions of radon inhalation 
The radon exposure system is shown in Fig. 1. To generate conditions for inhalation of 
radon concentration, we used a radon source that is in a tank (Radon Medical Treatment 
Research and Development Mechanism Ltd., Okayama, Japan). Air with radon was blown into 
the box from the tank (Fig. 1) at a rate of 0.2 L/min and blown out the box at a rate of 0.2 
L/min. Mice had free access to food and water during radon inhalation and the sham treatment. 
The radon concentration in the box was measured using a radon monitor (PQ2000, Genitron 
Instruments, Frankfurt, Germany). The mean concentration of the background and the 
radon-treatment concentration were approximately 20 Bq/m3 and 18 kBq/m3, respectively. 
 
Animals 
Male BALB/c mice (age, 7 weeks; body weight, approximately 25 g), which are sensitive to 
radiation compared with other strains, were obtained from the Department of Animal 
Resources Advanced Science Research Center Okayama University. Ethical approval was 
obtained from the animal experimental committee of Okayama University. Mice inhaled radon 
at a concentration of 18 kBq/m3 for 6 h. 4 ml/kg of CCl4 (5% in olive oil) was injected in to 
the peritoneum of the mice immediately after radon inhalation. Control and CCl4-injected 
mice were treated with sham radon inhalation. Twenty-four hours after CCl4 administration, 
blood was drawn from the heart for serum analysis under ether anesthesia, and livers and 
kidneys were quickly excised to analyze t-GSH content, lipid peroxide levels, and GPx and 
GR activity. Serum was separated by centrifugation at 3,000 × g for 5 min for the assays of 
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GOT, GPT, and ALP activity and the levels of T-CHO and CRE. These samples were 
preserved at -80 °C until biochemical assay. Liver and kidney tissue samples were fixed in 
10% neutral-buffered formalin for histological examinations. 
 
Biochemical assays 
Total glutathione content was measured using the Bioxytech GSH-420TM assay kit (OXIS 
Health Products, Inc., Portland, OR, USA). Briefly, tissue samples from liver or kidney were 
suspended in 10 mM phosphate buffer (pH 7.4), mixed with ice-cold 7.5% trichloroacetic acid 
solution, and homogenized. The homogenates were centrifuged at 3,000 × g for 10 min. The 
supernatants were used for the assay. Total glutathione content was measured at 420 nm using 
a spectrophotometer. This assay is based on the formation of a chromophoric thione the 
absorbance of which, measured at 420 nm, is directly proportional to the total glutathione 
concentration. The protein content was measured by the Bradford method, using Protein 
Quantification Kit-Rapid (Dojindo Molecular Technologies, Inc., Kumamoto, Japan) [26]. 
GPx activity was measured by using the BIOXYTECH GPx-340TM assay kit (OXIS Health 
Products, Inc.). Briefly, liver or kidney samples were homogenized in 1 M Tris-HCl buffer 
(pH 7.4) containing 5 mM ethylendiaminetetraacetic acid and 1 mM dithiothreitol. The 
homogenates were centrifuged at 10,000 × g for 20 min at 4 °C. The supernatants were used 
for the assay. The reduction of nicotinamide adenine dinucleotide phosphate (NADPH) to 
nicotinamide adenine dinucleotide phosphate (NADP+) is accompanied by a decrease in 
absorbance, measured at 340 nm, providing a spectrophotometric means for monitoring GPx 
enzyme activity. The molar extinction coefficient for NADPH is 6220 M-1 cm-1 at 340 nm. To 
assay GPx, the supernatant is added to a solution containing glutathione, GR, and NADPH. 
The enzyme reaction is initiated by adding a substrate, tert-butyl hydroperoxide, and 
absorbance at 340 nm is recorded for 3 min. 
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GR activity was assayed using the Bioxytech GR-340TM assay kit (OXIS Health Products, 
Inc.). Briefly, liver or kidney samples were homogenized in 1 M Tris-HCl buffer with 5 mM 
ethylendiaminetetraacetic acid (pH 7.4) on ice. The homogenates were centrifuged at 8,500 × 
g for 10 min. The supernatants were used for the assay. The assay is based on the oxidation of 
NADPH to NADP+ catalyzed by a limiting concentration of GR. One GR activity unit is 
defined as the amount of enzyme that catalyzes the reduction of 1 μmol of oxidized 
glutathione (GSSG) per minute at pH 7.4 and 25 °C. The reduction of GSSG is determined 
indirectly by the measurement of the consumption of NADPH, as demonstrated by a decrease 
in absorbance at 340 nm as a function of time. 
Lipid peroxide (malondialdehyde (MDA)) levels were assayed using the Bioxytech 
LPO-586TM assay kit (OXIS Health Products, Inc.). Briefly, liver or kidney samples were 
homogenized in 20 mM phosphate buffer (PBS; pH 7.4) on ice. Prior to homogenization, 10 
μL of 0.5 M butylated hydroxytoluene in acetonitrile were added per 1 mL of the buffer-tissue 
mixture. After homogenization, the homogenate was centrifuged at 15,000 × g, for 10 min at 
4 °C, and the supernatant was used for the assay. The MDA assay is based on the reaction of a 
chromogenic reagent, N-methyl-2-phenylidole, with MDA at 45 °C. The optical density of the 
colored products was read at 586 nm in a spectrophotometer. 
The serum activity of GOT, GPT, or ALP; the serum level of T-CHO and CRE; and the level 
of TG in liver were measured using TA-LN kainosu, TA-LN kainosu, ALP kainosu, T-CHO 
kainosu, TG-EN kainosu, and CRE-EN kainosu, respectively (Kainosu Co., Ltd., Tokyo, 
Japan). Briefly, blood was collected from the heart under ether anesthesia and serum was 
obtained by centrifugation at 3,000 × g for 5 min under 4 °C for the analyses of the activities 
of GOT, GPT, and ALP, and the levels of T-CHO and CRE. Liver samples were suspended in 
10 mM phosphate buffer (pH 7.4) and homogenized for the analyses of TG level in liver. 
Whole homogenate was used for the assay. GOT and GPT activity and the level of TG were 
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measured at 550 nm, ALP activity was measured at 498 nm, and the CRE level was measured 
at 515 nm using a spectrophotometer. 
 
Histological examination 
Liver and kidney samples were fixed in 10% formalin, processed with a graded mixture of 
ethanol and xylene and embedded in paraffin, and embedded in paraffin. Six-micrometer-thick 
tissue sections were prepared and stained with hematoxylin-eosin (HE). 
 
Statistical analyses 
The data values are presented as the mean ± standard error of the mean (SEM). The 
statistical significance of differences was determined by Student's t-test for comparison 
between two groups and Tukey’s tests for multiple comparisons where appropriate. 
 
RESULTS 
Effects of radon inhalation on hepatic or renal function 
The differences of hepatic or renal functions following radon inhalation for 6 h were 
examined. No significant differences were observed in GOT, GPT, or ALP activity and the 
level of T-CHO and CRE in serum between mice exposed to radon and control mice (Fig. 2A, 
C); similarly, the TG level in liver was not significantly different (Fig. 2B). 
 
Effects of radon inhalation on antioxidative function in liver and kidney 
The antioxidative function of liver and kidney in mice exposed to radon inhalation for 6 h 
were examined. The t-GSH content and the GPx and GR activity in liver were significantly 
higher, and the lipid peroxide level in liver significantly was significantly lower (Fig. 3A) in 
mice exposed to radon as compared to control mice. The t-GSH content and the activity of 
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GPx and GR in kidney were significantly higher, and the lipid peroxide level was significantly 
lower in the mice exposed to radon inhalation for 6 h (Fig. 3B). 
 
Effects of radon inhalation on hepatic or renal function following CCl4 administration 
  The effects of CCl4 administration on hepatic or renal function of mice pretreated with 
radon were examined. In mice injected with CCl4 in the absence of radon pretreatment, the 
activities of GOT, GPT, and ALP in serum were significantly higher and the T-CHO level in 
serum was significantly lower than in control animals (Fig. 4A, Table 1). The TG level in liver 
was significantly higher in the CCl4 group when compared to the control animals (Fig. 4B). 
However, the activities of GOT and ALP in serum and TG level in liver of CCl4 administrated 
only group were significantly higher than those of the radon inhalation pretreatment group 
(Fig. 4A, B, Table 1). The T-CHO level in serum of CCl4 administrated group was 
significantly lower than that of radon inhalation pretreatment group (Fig. 4A). In addition, 
CRE level in serum of CCl4 administrated group were significantly higher than those of radon 
inhaled group before CCl4 administration (Fig. 4C). 
 
Effects of radon inhalation on oxidative damage levels in mice liver and kidney following CCl4 
administration 
  To determine the protective effects of CCl4-induced hepatic and renal damage, various 
parameters of oxidative damage were assayed in livers and kidneys following radon inhalation. 
In mice injected with CCl4 in the absence of radon pretreatment, the GPx activity and the 
t-GSH content in liver were significantly lower and the lipid peroxide level in liver was 
significantly higher than in control animals. However, the activities of GPx and GR and the 
t-GSH content in liver of group pretreated with radon were significantly higher than those of 
CCl4 administrated group. Lipid peroxide level in liver of radon inhaled group before CCl4 
administration was significantly lower than that of CCl4 administrated group (Fig. 5A). 
The activities of GPx and GR and the t-GSH content in kidney were significantly lower and 
the lipid peroxide level in kidney was significantly higher than in control animals. However, 
the t-GSH content and the activity of GPx and GR in kidney of the group pretreated with 
radon were significantly higher and the lipid peroxide level in kidney was significantly lower 
than those of CCl4 administrated mice (Fig. 5B) 
 
Histological observation in liver and kidney following CCl4 administration 
  The effects of radon inhalation on the histology of livers and kidneys subjected to CCl4 
administration were examined. CCl4 administration resulted in centrilobular necrosis of the 
liver, and the necrosis in the CCl4 group was significantly greater than that in the group 
pretreated with radon (Fig. 6A, B). 
  In case of kidney, CCl4 administration resulted in dilatation of Bowman’s space and 
glomerular atrophy, and radon inhalation inhibited the dilatation of Bowman’s space and 
glomerular atrophy (Fig. 7). 
 
DISCUSSION 
Radon is an inert gas and as such does not react with any chemical component of the body. 
On entry through lungs, radon reaches the blood stream and is then distributed throughout the 
body. Therefore, many organs are subjected to the actions of free radicals created by the 
radiation. Radon is a source of α-rays, and these α-rays can only travel a distance of about 20 
μm through body tissues. The relatively large transfer of energy that is associated with the 
absorption of α-particles causes a series of complicated reactions within tissues. Radon 
inhalation has been reported to have therapeutic effects on senile brain disorder and 
hypertension [27]. Another known effect of a radon spring is to promote the effects of such 
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tissue perfusion agents as adrenaline in plasma; specifically, the level of plasma adrenaline is 
increased by radon inhalation [28,29]. We previously reported that radon inhalation of a 
concentration of 4000 Bq/m3 for 1 or 2 days significantly increases the antioxidative function 
of mouse liver and kidney [25]. In the current study, we attempted to shorten the inhalation 
time. Therefore, we needed to maintain as high a concentration of radon as possible. Although 
it is difficult to keep radon concentration levels up in the radon exposure box, our exposure 
system can maintain a radon concentration of 18 kBq/m3 over the time frame used in this 
experiment. The exposure dose of activation of antioxidative function may be estimated by 
multiplication of radon concentration and inhalation time. In fact, our results showed that 
t-GSH contents and the activities of GPx and GR in liver and kidney were significantly 
increased and lipid peroxide levels in liver and kidney were significantly decreased by radon 
inhalation, suggesting that radon inhalation activated antioxidative function. 
The oxidative stress induced by CCl4 is an established model for hepatotoxicity. The toxic 
effect of CCl4 is due to the peroxidation of the membrane lipids by the trichloromethyl radical 
or trichoromethyl peroxy radical [1,2]. These radicals initiate lipid peroxidation chain 
reactions and cause severe cell damage. This damage induces an increase in fat accumulation 
in liver. In addition, severe liver damage interferes with cholesterol synthesis in liver. The 
activities of GOT, GPT, and ALP and the level of T-CHO and TG are used as indicators of 
liver damage. In this study, CCl4 administration significantly increased the activities of GOT, 
GPT, and ALP in serum, and significantly decreased the serum T-CHO level. Moreover, TG 
level in liver significantly increased, suggesting that CCl4 induced hepatopathy. On the other 
hand, CRE level is used as an indicator of kidney damage. Our results show that CCl4 
significantly increased the CRE level in serum, suggesting that CCl4 administration also 
induced kidney damage. 
Glutathione reacts directly with ROS, and GPx catalyzes the destruction of hydrogen 
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peroxide and hydroxyl radical [30]. This catalysis generates GSSG and finally glutathione. 
However, GR catalyzes the regeneration of glutathione from GSSG. Thus, GR and GPx are 
both the enzymes in the glutathione-regenerating pathway, and the activity of these enzymes 
responded to the treatments used in our experiments in a similar fashion. Glutathione protects 
against CCl4-induced microsomal lipid peroxidation [31] and can scavenge trichloromethyl 
peroxy radical but not trichloromethyl radical [31]. Our results showed that CCl4 significantly 
decreased t-GSH contents and the activities of GPx and GR and significantly increased lipid 
peroxide level in liver and kidney. These results clearly indicated that CCl4 injection is 
associated with a weakening or failure of the antioxidative function in the liver or kidney. 
However, radon inhalation significantly activated antioxidative functions in liver and kidney. 
These results were consistent with the results in our previous reports [17,18]. Taken together, 
these findings suggest that radon inhalation has a similar biological effect to that of low-dose 
X-irradiation. 
It has been reported that pathological changes induced by CCl4 are mediated by induction of 
oxidative stress [32]. Lipid peroxidation induced by CCl4 causes membrane disruption, 
resulting in the loss of membrane integrity. Weakened cellular membranes allow sufficient 
leakage of calcium into the cytosol to disrupt intracellular calcium homeostasis. The increase 
in intracellular calcium can activate endonucleases that can cause chromosomal damage and 
also contribute to cell death [32]. In this study, livers subjected to CCl4 administration 
exhibited centrilobular necrosis, and the extent of centrilobular necrosis in CCl4-treated mice 
was greater than that of control mice. However, radon inhalation inhibited the centrilobular 
necrosis induced by CCl4 treatment. Moreover, our results indicated that the activation of 
antioxidative function inhibited lipid peroxidation in cellular membranes. This conclusion is 
also supported by the increased hepatic function (e.g., GOT, GPT, and ALP activity) 
associated with radon inhalation. 
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It has been reported that CCl4 administration induced mild dilatation of Bowman’s space 
with glomerular atrophy [33]. Our results also revealed a mild dilatation of Bowman’s space 
with glomerular atrophy. However, antioxidants such as caffeic acid phenethyl ester protect 
against kidney damage induced by CCl4 [33]. In this study, radon inhalation significantly 
increased t-GSH contents and GPx and GR activity and mitigated the mild dilatation of 
Bowman’s space with glomerular atrophy, suggesting that glutathione protected the kidney 
from damage induced by CCl4. This conclusion was also supported by an increase in serum 
CRE level associated with radon treatment. 
The radon therapy is performed for various diseases, such as ankylosing spondylitis, 
chronic polyarthritis, spondylosis deformans, osteoarthritis, and bronchial asthma, at Misasa 
Medical Center, Okayama University Hospital. Hepatic and renal damage are not the main 
indications for radon therapy. However, our results demonstrated that radon inhalation clearly 
inhibited oxidative damage of liver and kidney. The data presented in this study provide a 
substantial basis for future studies aimed at assessing new radon-based therapies for treatment 
of hepatic and renal damage in humans. 
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Figure Legends 
 
Fig. 1 Schematic diagram of the radon exposure system. 
Fig. 2 Changes in hepatic function-associated parameters in the serum (A), TG level in liver 
(B) and renal function-associated parameters in the serum (C) of radon inhalation and 
control mice. Each value indicates the mean ± SEM. The number of mice per 
experimental point was 5-6. 
Fig. 3 Changes in antioxidant-associated parameters in the liver (A) and kidney (B) of radon 
inhalation and control mice. Each value indicates the mean ± SEM. The number of mice 
per experimental point was 5-6. *P < 0.05, ***P < 0.001 vs Control. 
 
Fig. 4 Effects of radon inhalation on hepatic function-associated parameters in the serum (A), 
TG level in liver (B) and renal function-associated parameters in the serum (C) of CCl4 
administrated mice. Each value indicates the mean ± SEM. The number of mice per 
experimental point is 4-6. **P < 0.01, ***P < 0.001 vs Control, #P < 0.05, ##P < 0.01 vs 
CCl4. 
 
Fig. 5 Effects of radon inhalation on antioxidative-associated parameters in the serum (A) and 
kidney (B) in mice injected with CCl4. Each value indicates the mean ± SEM. The 
number of mice per experimental point was 4-6. *P < 0.05, **P < 0.01 vs Control, #P < 
0.05, ##P < 0.01 , ###P < 0.001vs CCl4. 
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Fig. 6 Effect of radon inhalation on CCl4-induced liver damage in mouse. Mouse livers were 
examined histologically. (A) Control, (B) CCl4 administration, (C) radon inhalation 
before CCl4 administration. The length of the scale bar is 50 μm. All samples were 
stained with HE. The area of cell necrosis surrounding the central vein (cv), but not 
portal vein (pv), in the CCl4-administrated mice was measured (D). Less area was 
damaged in the mice pretreated with radon relative to those treated with only CCl4 
administration. Each value indicates the mean ± SEM. The number of mice per 
experimental point was 6. **P < 0.01 vs CCl4. 
 
 
Fig. 7 Effect of radon inhalation on CCl4-induced kidney damage in mouse. Mouse kidneys 
were examined histologically. (A) Control, (B) CCl4 administration, (C) radon 
inhalation before CCl4 administration. The length of the scale bar is 50 μm. All samples 
were stained with HE. The arrow indicates dilatation of Bowman’s space with 
glomerular atrophy.  
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Fig.6 
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 Table.1 Effects of radon inhalation on hepatic function-associated 
parameters in the serum of CCl4 administrated mice. Each 
value indicates the mean ± SEM. The number of mice per 
experimental point is 5-6. ***P <0.001 vs Control, ##P <
0.01 vs CCl4.
Control CCl4 Rn+CCl4
GOT Activity [K-U]
GPT Activity [K-U]
63 ± 15 22121 ± 1314*** 15055±359***, ##
19± 1 16170 ± 1364*** 14965 ± 1409***
(n=6) (n=5) (n=5)
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